|
|
Volumn 33, Issue 3, 2008, Pages 219-226
|
|
Lenalidomide in the treatment of multiple myeloma: A review
a,b,d
|
|
Author keywords
Immunomodulatory drugs; Lenalidomide; Myeloma
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BORTEZOMIB;
DEXAMETHASONE;
DOXORUBICIN;
IMMUNOMODULATING AGENT;
LENALIDOMIDE;
LOW MOLECULAR WEIGHT HEPARIN;
MELPHALAN;
THALIDOMIDE;
VINCRISTINE;
WARFARIN;
ANEMIA;
ANTIANGIOGENIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
ASTHENIA;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER GROWTH;
CANCER RELAPSE;
CANCER SURVIVAL;
CELL PROLIFERATION;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONSTIPATION;
CYTOPENIA;
DEEP VEIN THROMBOSIS;
DIARRHEA;
DRUG DISPOSITION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG TOLERABILITY;
FATIGUE;
FEBRILE NEUTROPENIA;
HEART ATRIUM FIBRILLATION;
HUMAN;
HYPERGLYCEMIA;
IMMUNOMODULATION;
INFECTION;
LUNG EMBOLISM;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
MUSCLE CRAMP;
NEUROPATHY;
NEUTROPENIA;
NONHUMAN;
PNEUMONIA;
RASH;
REVIEW;
SOMNOLENCE;
TERATOGENICITY;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOSIS;
TREATMENT RESPONSE;
|
|
EID: 43049086661
PISSN: 02694727
EISSN: 13652710
Source Type: Journal
DOI: 10.1111/j.1365-2710.2008.00920.x Document Type: Review |
|
Times cited : (75)
|
|
References (45)
|
